Suicidal Ideation — Repetitive Transcranial Magnetic Stimulation as Treatment for Acute Suicidality in Adult Patients
Citation(s)
Beck AT, Kovacs M, Weissman A Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979 Apr;47(2):343-52.
Beck AT Beck Hopelessness Scale. The Psychological Corporation; 1988.
Borckardt JJ, Nahas Z, Koola J, George MS Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT. 2006 Sep;22(3):169-75.
Buchwald A Too soon to say goodbye. 1st ed. New York: Random house; 2006.
Burton CZ, Vella L, Weller JA, Twamley EW Differential effects of executive functioning on suicide attempts. J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):173-9. doi: 10.1176/appi.neuropsych.23.2.173.
Counter SA, Borg E, Lofqvist L, Brismar T Hearing loss from the acoustic artifact of the coil used in extracranial magnetic stimulation. Neurology. 1990 Aug;40(8):1159-62.
HAMILTON M A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62.
Hamilton M Diagnosis and rating of anxiety. The British journal of psychiatry : the journal of mental science. 1969;3:76-9.
Heins SE, Crifasi CK Distinctive injury deaths: the role of environment, policy and measurement across states. Inj Prev. 2016 Aug;22(4):247-52. doi: 10.1136/injuryprev-2015-041833. Epub 2016 Jan 24.
Mann JJ Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003 Oct;4(10):819-28. Review.
Martin-Soelch C Is depression associated with dysfunction of the central reward system? Biochem Soc Trans. 2009 Feb;37(Pt 1):313-7. doi: 10.1042/BST0370313. Review.
Martino DJ, Strejilevich SA, Torralva T, Manes F Decision making in euthymic bipolar I and bipolar II disorders. Psychol Med. 2011 Jun;41(6):1319-27. doi: 10.1017/S0033291710001832. Epub 2010 Sep 22.
Owen AM, McMillan KM, Laird AR, Bullmore E N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp. 2005 May;25(1):46-59.
Pascual-Leone A, Gates JR, Dhuna A Induction of speech arrest and counting errors with rapid-rate transcranial magnetic stimulation. Neurology. 1991 May;41(5):697-702.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.
Roth BJ, Pascual-Leone A, Cohen LG, Hallett M The heating of metal electrodes during rapid-rate magnetic stimulation: a possible safety hazard. Electroencephalogr Clin Neurophysiol. 1992 Apr;85(2):116-23.
Vohs KD, Baumeister R Escaping the self consumes regulatory resources: a self-regulatory model of suicide. Suicide Science. 2002:33-41.
Wassermann EM Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998 Jan;108(1):1-16.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.